TRT blood testing advice on TikTok: what the science says
Quick answer
The video addresses pre-TRT blood testing methodology, specifically debating capillary versus venous testosterone sampling, in the context of men self-investigating possible hypogonadism. Endocrine Society guidelines require two morning venous testosterone measurements below the established threshold before a hypogonadism diagnosis, meaning the type, timing, and frequency of testing all carry clinical weight. The creator's offer to personally interpret followers' results and advise on TRT eligibility falls outside lay advice and into territory that warrants involvement from a qualified prescribing clinician.
Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team· This is not a transcript. It is our independent review of the video above.
What did @harveylonsdale_ actually say?
The claim is simple: finger prick hormone panels are "incredibly unreliable" because they only measure hormones in a small blood volume, and anyone serious about TRT should opt for a venous draw instead. He also recommends getting a full blood panel rather than just a hormone panel, so you can catch other health markers that might be affecting how you feel.
He frames this as practical advice for men considering testosterone replacement, and closes by offering to personally review blood results for followers thinking about starting TRT. The recommendation to use Medichecks.com as the testing provider is in the caption, not the spoken content.
On the surface, this sounds reasonable. Venous blood draws are the clinical standard. Full panels do give you more information. But the specific claim that finger prick tests are "incredibly unreliable" deserves a harder look, because the evidence is more complicated than a flat dismissal.
Does the science back this up?
Partly, but not as cleanly as the video implies. The reliability of capillary blood sampling depends heavily on collection technique, not just sample volume. Several studies have found reasonable agreement between finger prick and venous draws when done correctly.
A 2021 study by Shephard et al. in the Annals of Clinical Biochemistry compared capillary and venous testosterone samples and found that while there was some variability, the differences were often within clinically acceptable ranges for screening purposes. The authors noted that poor technique, including squeezing the finger or diluting the sample with tissue fluid, is where most of the error comes from. That is a training and protocol issue, not an inherent flaw in capillary sampling.
That said, for clinical decision-making around TRT, the Endocrine Society guidelines do recommend venous draws as the standard method for testosterone measurement. There are also known issues with certain immunoassay platforms used in at-home kits, which can introduce variability beyond just the collection method. So the recommendation to go venous is defensible. The claim that finger pricks are "incredibly unreliable" as a category is an overstatement.
What did they get wrong (or right)?
He gets the directional advice right. If you are making a clinical decision about whether to start TRT, a venous draw processed through a proper laboratory is the appropriate choice. Clinicians agree on this.
Where he oversimplifies is in the mechanism. He says finger pricks only measure hormones in a "small amount of blood" as though volume alone is the problem. Volume is not the main issue. Modern laboratory assays can work with very small samples. The actual concerns are haemoconcentration from slow capillary flow, tissue fluid contamination from squeezing, and platform-specific variability in certain point-of-care or postal testing kits. These are technique and platform problems, not a fundamental limitation of capillary blood.
His advice to review the full blood panel rather than just hormones is genuinely good. Conditions like anaemia, thyroid dysfunction, elevated liver enzymes from prior supplement use, and metabolic markers all interact with how a man feels and responds to hormone therapy. Looking only at testosterone without context is a common and avoidable mistake.
The offer to personally review followers' blood results is where this video raises a flag. Interpreting blood work and advising someone on whether they "qualify" for TRT is a clinical act. It should happen with a licensed provider who has access to full medical history.
What should you actually know?
If you are getting blood work ahead of a TRT consultation, a venous draw is the right call. Not because finger prick samples are inherently useless, but because you want the most defensible result when making a significant hormonal decision, and venous samples processed through accredited labs have the smallest margin for technique-related error.
The Endocrine Society's 2018 clinical practice guidelines on male hypogonadism specify that testosterone should be measured by a reliable assay in the morning, on at least two separate occasions, before a diagnosis of hypogonadism is made. One blood test, by any method, is not enough to make the call.
A comprehensive panel beyond hormones is worth the extra cost. Haematocrit, liver function, lipid profile, PSA if age-appropriate, thyroid function, and a full blood count all matter before and during TRT. These markers can reveal contraindications or complicating factors that a hormone-only panel will miss entirely.
Finally, if someone on social media, regardless of their own TRT experience, is offering to read your blood results and advise whether you qualify for hormone therapy, that is not a substitute for a licensed clinician. Use that conversation as a starting point, not a diagnosis.
Video review standard
Clinical fact-check snapshot
FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.
Evidence signal
Source-backed review
Regulatory reality
Access rules depend on the compound and patient situation
Safety screen
Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.
This page currently connects to 6 source-backed evidence items through visible references or structured citation data.
PubMed evidence trail
Research sources used to frame this page
For TRT blood testing advice on TikTok: what the science says, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Cardiovascular Safety of Testosterone-Replacement Therapy
TRAVERSE trial anchor for cardiovascular-safety discussions in appropriately diagnosed men.
PubMed
Testosterone therapy in men with androgen deficiency syndromes: an Endocrine Society clinical practice guideline
Guideline anchor for diagnosis, monitoring, contraindications, and appropriate TRT framing.
PubMed
NAD+ metabolism and its roles in cellular processes during ageing
Core review for NAD+ decline, mitochondrial function, DNA repair, and aging biology.
PubMed
Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women
Human NMN source for metabolic claims while keeping population limits clear.
PubMed
Provider decision path
Use local research to choose a safer review path
Direct answer
TRT blood testing advice on TikTok: what the science says is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.
Evidence check
Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.
Safety check
Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.
Next step
Compare providers, services and access requirements in the directory before contacting a suitable care team.
Claim path
Keep researching this testosterone and trt video claims cluster
Best for searchers turning TRT social claims into a safer lab-backed provider discussion.
Claim verdict
The useful answer behind this video
Claim being checked
The video addresses pre-TRT blood testing methodology, specifically debating capillary versus venous testosterone sampling, in the context of men self-investigating possible hypogonadism.
FormBlends verdict
The video addresses pre-TRT blood testing methodology, specifically debating capillary versus venous testosterone sampling, in the context of men self-investigating possible hypogonadism. Endocrine Society guidelines require two morning venous testosterone measurements below the established threshold before a hypogonadism diagnosis, meaning the type, timing, and frequency of testing all carry clinical weight. The creator's offer to personally interpret followers' results and advise on TRT eligibility falls outside lay advice and into territory that warrants involvement from a qualified prescribing clinician.
Patient-safe next step
Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.
What to do with this video
Use the clip as a claim to verify, not a treatment plan
What it helps with
- The video addresses pre-TRT blood testing methodology, specifically debating capillary versus venous testosterone sampling, in the context of men self-investigating possible hypogonadism. Endocrine Society guidelines require two morning venous testosterone measurements below the established threshold before a hypogonadism diagnosis, meaning the type, timing, and frequency of testing all carry clinical weight. The creator's offer to personally interpret followers' results and advise on TRT eligibility falls outside lay advice and into territory that warrants involvement from a qualified prescribing clinician.
- The Endocrine Society (Bhasin et al., 2018, JCEM) requires two separate morning venous testosterone measurements below the clinical threshold before diagnosing hypogonadism. One test is never enough.
- Finger prick test variability is driven primarily by collection technique and assay platform, not sample volume. Shephard et al. (2021, Annals of Clinical Biochemistry) showed capillary and venous results can agree closely when protocol is followed.
What it may miss
- It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
- Compound access, legal status, and product quality still need a separate safety check.
- Social video captions rarely show the full evidence base behind a claim.
Best next step
Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.
Start provider reviewWhat You'll Learn
- The Endocrine Society (Bhasin et al., 2018, JCEM) requires two separate morning venous testosterone measurements below the clinical threshold before diagnosing hypogonadism. One test is never enough.
- Finger prick test variability is driven primarily by collection technique and assay platform, not sample volume. Shephard et al. (2021, Annals of Clinical Biochemistry) showed capillary and venous results can agree closely when protocol is followed.
- Venous draws processed through accredited laboratories are still the recommended standard for pre-TRT testing, giving the most defensible result for clinical decision-making.
- A full blood panel before TRT should include haematocrit, liver function tests, lipid profile, thyroid function, and age-appropriate PSA, not just testosterone and sex hormones.
- Timing matters as much as method. Testosterone follows a diurnal pattern, peaking in the morning. Samples drawn outside this window can artificially lower readings and skew clinical interpretation.
- Social media-based blood result reviews are not a substitute for clinical consultation. TRT is a regulated medical intervention and eligibility should be assessed by a licensed prescribing clinician with your full medical history.
- Medichecks and similar at-home venous postal testing services use accredited laboratories and are considered acceptable for initial screening by many UK clinicians, though results should always be reviewed in a clinical context.
Interested in GLP-1 or peptide therapy?
Get matched with licensed-provider review to help decide if it is right for you.
About the Creator
Modern Man Clinic · TikTok creator
24.1K views on this video
🩸 If your getting your bloods done for TRT, we like to use medichecks.com (we don’t have a code yet 😔) Splash out was the wrong word, ideally you want the advanced test - if your looking to get on top of your hormones you should also be looking too optimise all of your bloodwork 👌🏼 Male hormone blood test is £79.99 & an additional £35 for a venous draw (Recommended) Advanced TRT Blood test £149 & £35 for venous draw 👊🏼 Hope it helps 🤝🏼 #blood #trt #trtjourney #fitness #menshealt
Read More on This Topic
Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.
Not medical advice. This video was made by Modern Man Clinic, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.